Company Name: Supernus Pharmaceuticals, Inc.    

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company is engaged in the development and commercialization of treatments for central nervous system diseases. The company has two marketed products for the treatment of epilepsy and a developmental pipeline that includes product candidates for ADHD and impulsive aggression in patients with ADHD.

Ticker Symbol: SUPN (NASDAQ)

Company Website: www.supernus.com

Social Media: Supernus Pharmaceuticals LinkedIn Page

Headquarters: Rockville, MD